Cargando…

Risk factors of postoperative recurrences in patients with clinical stage I NSCLC

BACKGROUND: Despite advances in radiation therapy, chemotherapy, and newly developed molecular targeting therapies, long-term survival after resection for patients with NSCLC remains less than 50%. We investigated factors predicting postoperative locoregional recurrences and distant metastases in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ying-Yi, Huang, Tsai-Wang, Tsai, Wen-Chiuan, Lin, Li-Fan, Cheng, Jian-Bo, Chang, Hung, Lee, Shih-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895770/ https://www.ncbi.nlm.nih.gov/pubmed/24410748 http://dx.doi.org/10.1186/1477-7819-12-10

Ejemplares similares

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm
por: Huang, Chien‐Sheng, et al.
Publicado: (2020)

Initial presentation of tonsillar carcinoma with candidiasis
por: Shih, Cheng-Ping, et al.
Publicado: (2019)

Prognostic Impact of EBUS TBNA for Lung Adenocarcinoma Patients with Postoperative Recurrences
por: Chen, Ying-Yi, et al.
Publicado: (2022)

Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC
por: Patnaik, Santosh K., et al.
Publicado: (2021)

Brief report: risk stratification following curative therapy for stage I NSCLC
por: Butts, Emily, et al.
Publicado: (2023)

Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients with Stage III Gastric Cancer
por: Hsueh, Shun-Wen, et al.
Publicado: (2019)

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
por: Chang, Wei-Yuan, et al.
Publicado: (2018)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Time-Varying Pattern of Postoperative Recurrence Risk of Early-Stage (T1a-T2bN0M0) Non-Small Cell Lung Cancer (NSCLC): Results of a Single-Center Study of 994 Chinese Patients
por: Zhu, Jian-fei, et al.
Publicado: (2014)

Risk factors of recurrence in TNM stage I colorectal cancer
por: Paik, Jin-Hee, et al.
Publicado: (2023)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

PSMB8 inhibition decreases tumor angiogenesis in glioblastoma through vascular endothelial growth factor A reduction
por: Chang, Hsin‐Han, et al.
Publicado: (2020)

An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study
por: Su, Po-Lan, et al.
Publicado: (2022)

Postoperative ctDNA detection predicts relapse but has limited effects in guiding adjuvant therapy in resectable stage I NSCLC
por: Wang, Bolin, et al.
Publicado: (2023)

Loss of the Drosophila branched-chain α-ketoacid dehydrogenase complex results in neuronal dysfunction
por: Tsai, Hui-Ying, et al.
Publicado: (2020)

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway
por: Liu, Yi-Nan, et al.
Publicado: (2020)

APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC
por: Li, Yanping, et al.
Publicado: (2021)

Risk factors for postoperative recurrence in patients with stage II colorectal cancer
por: Xiong, Zhi-Zhong, et al.
Publicado: (2023)

Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC
por: Zhang, Haoran, et al.
Publicado: (2023)

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC
por: Lee, Jay M., et al.
Publicado: (2023)

A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer
por: Chang, Yu-Tang, et al.
Publicado: (2016)

KDELC2 Upregulates Glioblastoma Angiogenesis via Reactive Oxygen Species Activation and Tumor-Associated Macrophage Proliferation
por: Tsai, Yu-Ling, et al.
Publicado: (2023)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Qiu, Bin, et al.
Publicado: (2021)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance
por: Tsai, Yu-Ling, et al.
Publicado: (2020)

Glia-derived exosomal miR-274 targets Sprouty in trachea and synaptic boutons to modulate growth and responses to hypoxia
por: Tsai, Yi-Wei, et al.
Publicado: (2019)

A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection
por: Hu, Chunhong, et al.
Publicado: (2022)

Predictive Value of (18)F-FDG PET and CT Morphologic Features for Recurrence in Pathological Stage IA Non-Small Cell Lung Cancer
por: Ko, Kai-Hsiung, et al.
Publicado: (2015)

Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection
por: Wu, Yu-Chung, et al.
Publicado: (2017)

Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC
por: Donington, Jessica S.
Publicado: (2022)

Timely Curative Treatment and Overall Mortality Among Veterans With Stage I NSCLC
por: Sanchez, Rolando, et al.
Publicado: (2022)

Inhibition of FABP6 Reduces Tumor Cell Invasion and Angiogenesis through the Decrease in MMP-2 and VEGF in Human Glioblastoma Cells
por: Pai, Feng-Cheng, et al.
Publicado: (2021)

Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC
por: Cheng, Fang-Ju, et al.
Publicado: (2020)

Fucosyl-Agalactosyl IgG(1) Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage
por: Chang, Ting-Tsung, et al.
Publicado: (2018)

Effect of multidisciplinary team care on the risk of recurrence in breast cancer patients: A national matched cohort study
por: Tsai, Chang-Hung, et al.
Publicado: (2020)

Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression
por: Chen, Zhiwei, et al.
Publicado: (2017)

Cost-Effectiveness Analysis from a Societal Perspective of Recurrence Index for Distant Recurrence (RecurIndex) in Women with Hormone Receptor-Positive and HER2-Negative Early-Stage Breast Cancer
por: Pennarun, Nicolas, et al.
Publicado: (2022)

Pulmonary metastatic angiosarcoma from scalp with fatal complication: A case report
por: Cheng, Yung-Sheng, et al.
Publicado: (2017)

Baseline risk of recurrence in stage I–II endometrial carcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ggpd7q97mi2eu40lbcq1ini41u